Driscoll Children's Hospital Respiratory Syncytial Virus Database: Risk Factors, Treatment and Hospital Course in 3308 Infants and Young Children, 1991 to 2002

Pediatric Infectious Disease Journal

Volumn 23, Issue 5, 2004, Pages 418-423

  Purcell, Kevin ^a,b,d   Fergie, Jaime ^c,d  

^a Healthcare and Leadership Solutions   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c DRISCOLL CHILDREN S HOSPITAL   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Bronchiolitis; Pediatric intensive care unit admissions; Respiratory syncytial virus; Ribavirin; Risk factors

Indexed keywords

CEPHALOSPORIN; RIBAVIRIN;

AGE; ARTIFICIAL VENTILATION; CHILD HOSPITALIZATION; CONGENITAL HEART DISEASE; DATA BASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HOSPITAL CARE; HUMAN; INFANT; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; PEDIATRIC HOSPITAL; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SEASON; VIROLOGY; VIRUS INFECTION;

ANTIVIRAL AGENTS; DATABASES, FACTUAL; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS; LENGTH OF STAY; MEDICAL RECORDS; PEDIATRICS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RIBAVIRIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENTILATORS, MECHANICAL;

EID: 2442475140     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000126273.27123.33     Document Type: Review

References (17)

1. Purcell K, Fergie J. Effect of an educational program on the treatment of RSV lower respiratory tract infection. Am J Health-Syst Pharm. 2003; 60:759-767.
2. Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with RSV lower respiratory tract infection. Arch Pediatr Adolesc Med. 2002;156:322-324.
3. Purcell K, Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2002;23:267-269.
4. American Academy of Pediatrics Committee on Infectious Diseases. Ribavirin therapy of respiratory syncytial virus. Pediatrics. 1987;79: 475-478.
5. American Academy of Pediatrics Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics. 1993;92:501-504.
6. American Academy of Pediatrics Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infection. Pediatrics. 1996;97:137-139.
7. Wang EEL, Law BJ, Stephens D, and other members of the PICNIC. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126:212-219.
8. Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J. 2003;22:S33-S39.
9. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J. 2003;22:S40-S45.
10. Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatric Infect Dis J. 2003;22:483-489.
11. Chan PW, Lok FY, Khatijah SB. Risk factors for hypoxemia and respiratory failure in respiratory syncytial virus bronchiolitis. Southeast Asian J Trop Med Public Health. 2002;33:806-810.
12. Feldstein TJ, Swegarden JL, Atwood GF, Peterson CD. Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy. Pediatrics. 1995;96:14-17.
13. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics. 1999;104:1334-1341.
14. Todd J, Bertoch D, Dolan S. Use of a large national database for comparative evaluation of the effect of a bronchiolitis/viral pneumonia clinical care guideline on patient outcome and resource utilization. Arch Pediatr Adolesc Med. 2002;156:1086-1090.
15. Law BJ, Wang EEL, MacDonald N, et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Pediatrics. 1997;99:E7.
16. Purcell K, Fergie J. Risk factors and PICU admissions in 3308 infants and young children hospitalized for treatment of RSV lower respiratory tract infections at Driscoll Children's Hospital, 1991-2002 [Abstract 1936]. Pediatr Res. 2003;53:339A.
17. Purcell K, Fergie J. Ribavirin use and hospital course in 3308 infants and young children hospitalized for treatment of RSV lower respiratory tract infections at Driscoll Children's Hospital, 1991-2002 [Abstract 1937]. Pediatr Res. 2003;53:339A-340A.